Companhia Brasileira de Alumínio Valuation
Is CBAV3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Sales vs. similares
Price-To-Sales vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of CBAV3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: CBAV3 (R$4.89) cotiza por encima de nuestra estimación de valor razonable (R$4.58)
Muy por debajo del valor justo: CBAV3 cotiza por encima de nuestra estimación del valor razonable.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CBAV3?
Other financial metrics that can be useful for relative valuation.
What is CBAV3's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | R$3.18b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.8x |
Enterprise Value/EBITDA | -13.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CBAV3's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.8x | ||
FESA4 Cia de Ferro Ligas da Bahia - FERBASA | 1.2x | n/a | R$3.8b |
RANI3 Irani Papel e Embalagem | 1.4x | 5.4% | R$2.2b |
GOAU4 Metalurgica Gerdau | 0.2x | n/a | R$11.2b |
USIM5 Usinas Siderúrgicas de Minas Gerais | 0.5x | -0.5% | R$12.5b |
CBAV3 Companhia Brasileira de Alumínio | 0.4x | 6.3% | R$3.2b |
Price-To-Sales vs. similares: CBAV3 es un buen valor basado en su Ratio Price-To-Sales (0.3x) comparado con la media de sus homólogos (1.4x).
Price to Earnings Ratio vs Industry
How does CBAV3's PE Ratio compare vs other companies in the South American Metals and Mining Industry?
Price-To-Sales vs. Industria: CBAV3 es un buen valor basado en su Ratio Price-To-Sales (0.3x) comparado con la media del sector South American Metals and Mining (0.5x).
Price to Sales Ratio vs Fair Ratio
What is CBAV3's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.4x |
Fair PS Ratio | 0.3x |
PM vs. Ratio Justo: CBAV3 es caro en función de su Ratio Price-To-Sales (0.4x) comparado con el Ratio Price-To-Sales estimado (0.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | R$4.89 | R$5.39 +10.1% | 11.2% | R$6.00 | R$4.50 | n/a | 7 |
Apr ’25 | R$4.06 | R$5.73 +41.0% | 18.5% | R$8.10 | R$4.50 | n/a | 8 |
Mar ’25 | R$4.03 | R$5.83 +44.5% | 18.1% | R$8.10 | R$4.50 | n/a | 8 |
Feb ’25 | R$3.98 | R$5.83 +46.4% | 18.1% | R$8.10 | R$4.50 | n/a | 8 |
Jan ’25 | R$5.10 | R$5.64 +10.5% | 18.7% | R$8.10 | R$4.50 | n/a | 8 |
Dec ’24 | R$4.10 | R$5.91 +44.2% | 15.8% | R$8.10 | R$5.00 | n/a | 8 |
Nov ’24 | R$3.81 | R$7.41 +94.6% | 50.3% | R$17.00 | R$5.00 | n/a | 8 |
Oct ’24 | R$4.57 | R$7.60 +66.3% | 47.9% | R$17.00 | R$5.20 | n/a | 8 |
Sep ’24 | R$4.52 | R$7.66 +69.5% | 47.2% | R$17.00 | R$5.20 | n/a | 8 |
Aug ’24 | R$5.29 | R$9.25 +74.9% | 49.4% | R$17.00 | R$6.00 | n/a | 8 |
Jul ’24 | R$5.04 | R$10.25 +103.4% | 40.5% | R$17.00 | R$6.00 | n/a | 8 |
Jun ’24 | R$5.22 | R$11.25 +115.5% | 34.1% | R$17.00 | R$6.00 | n/a | 8 |
May ’24 | R$5.28 | R$13.39 +153.6% | 24.0% | R$18.00 | R$9.00 | n/a | 9 |
Apr ’24 | R$7.58 | R$15.28 +101.6% | 10.8% | R$18.00 | R$13.00 | R$4.06 | 9 |
Mar ’24 | R$10.69 | R$14.94 +39.7% | 9.5% | R$17.00 | R$13.00 | R$4.03 | 8 |
Feb ’24 | R$12.50 | R$14.94 +19.5% | 9.5% | R$17.00 | R$13.00 | R$3.98 | 8 |
Jan ’24 | R$11.55 | R$15.75 +36.4% | 10.4% | R$17.00 | R$13.00 | R$5.10 | 8 |
Dec ’23 | R$11.97 | R$15.88 +32.6% | 9.1% | R$17.00 | R$14.00 | R$4.10 | 8 |
Nov ’23 | R$11.32 | R$17.25 +52.4% | 16.8% | R$24.00 | R$14.00 | R$3.81 | 8 |
Oct ’23 | R$11.44 | R$17.38 +51.9% | 16.0% | R$24.00 | R$14.00 | R$4.57 | 8 |
Sep ’23 | R$12.95 | R$18.38 +41.9% | 20.4% | R$25.00 | R$14.00 | R$4.52 | 8 |
Aug ’23 | R$11.11 | R$19.67 +77.0% | 19.6% | R$25.00 | R$14.00 | R$5.29 | 6 |
Jul ’23 | R$10.95 | R$21.17 +93.3% | 12.6% | R$25.00 | R$17.00 | R$5.04 | 6 |
Jun ’23 | R$16.30 | R$20.83 +27.8% | 15.8% | R$25.00 | R$17.00 | R$5.22 | 6 |
May ’23 | R$17.14 | R$22.33 +30.3% | 16.9% | R$25.00 | R$17.00 | R$5.28 | 3 |
Apr ’23 | R$19.93 | R$22.33 +12.1% | 16.9% | R$25.00 | R$17.00 | R$7.58 | 3 |
Pronóstico de los analistas: El precio objetivo es inferior a 20% superior al precio actual de la acción.